Business · 18/12/2013Updated: 10/17/2026 · 1 min read
FDA and CMS Extend Pilot Program for Parallel Review of Medical Products for 2 Years
Summary
The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have decided to extend the Pilot Program for Parallel Review of Medical Products for an additional 2 years, starting from the date of publication of this notice.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →